Local Amlodipine Generics Are Gaining Market Shares

Published: 2005-03-22 07:00:00

Updated: 2005-03-22 07:00:00

According to the report released by Bestcare, the analysis on the domestic sales and market shares of amlodipine-based antihypertensive medications shows that the local first-version generics are progressively gaining their market shares since July of last year, when Pfizer Korea's Novarsc, the o...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK